Jim Cahill

It’s part of the company’s effort to retool after taking back control of the drug from Sanofi.

Una fuerza policía en Arizona emplea los tres.

5 takeaways from a recent earnings call with the leading CGM maker.

A victim of mistaken identity, Demarcus Alexander ended up in the hospital in the aftermath of the shooting of six…

The company plans to submit the pump system for FDA approval in 2017.

It expands who can provide diabetes care during the school day.

If adopted, the proposed regulations would sanction Dexcom G5 users to dose based on CGM readings.

She joins another team and gets poetic justice during a tournament at season’s end.

A pair of new bills might help decentralize in-school diabetes care a bit.

Diabetes advocacy slams up against a complicated lawmaking process in the Pennsylvania legislature.

That accelerated process may soon yield Medtronic’s application to bring an artificial pancreas to market.

The popular Type 2 medication is already being used off-label as an add-on to insulin therapy.

A family of a six-year-old files complaints to end what they view as discrimination against children with diabetes.

Two judges say the device is necessary, not precautionary. Will this end the debate?

Mannkind officials discuss the future of their inhaled insulin during an earnings call.

Research points to the need for additional support for children with diabetes in school settings.

A pair of lawsuits alleges medical negligence in the New York City prison system.

Or...How Not to Calculate Your Insulin Dose When Committing a Crime.

An anthology of the cases which have determined the level of protection people with diabetes receive from workplace discrimination.

The two organizations announce a $4.6 million effort to bring smart insulin, insulin patches to the marketplace.